- Home
- SMHI vs NKTX Comparison
SMHI vs NKTX Comparison
Compare SMHI & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- NKTX
- Stock Information
- Founded
- SMHI 1989
- NKTX 2015
- Country
- SMHI United States
- NKTX United States
- Employees
- SMHI N/A
- NKTX N/A
- Industry
- SMHI Marine Transportation
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- NKTX Health Care
- Exchange
- SMHI Nasdaq
- NKTX Nasdaq
- Market Cap
- SMHI 185.8M
- NKTX 170.8M
- IPO Year
- SMHI N/A
- NKTX 2020
- Fundamental
- Price
- SMHI $6.40
- NKTX $2.05
- Analyst Decision
- SMHI
- NKTX Strong Buy
- Analyst Count
- SMHI 0
- NKTX 5
- Target Price
- SMHI N/A
- NKTX $15.20
- AVG Volume (30 Days)
- SMHI 126.4K
- NKTX 853.6K
- Earning Date
- SMHI 03-03-2025
- NKTX 03-20-2025
- Dividend Yield
- SMHI N/A
- NKTX N/A
- EPS Growth
- SMHI N/A
- NKTX N/A
- EPS
- SMHI N/A
- NKTX N/A
- Revenue
- SMHI $274,636,000.00
- NKTX N/A
- Revenue This Year
- SMHI $0.20
- NKTX N/A
- Revenue Next Year
- SMHI $2.00
- NKTX N/A
- P/E Ratio
- SMHI N/A
- NKTX N/A
- Revenue Growth
- SMHI 3.89
- NKTX N/A
- 52 Week Low
- SMHI $5.80
- NKTX $1.96
- 52 Week High
- SMHI $15.36
- NKTX $16.24
- Technical
- Relative Strength Index (RSI)
- SMHI 38.72
- NKTX 39.74
- Support Level
- SMHI $6.60
- NKTX $1.96
- Resistance Level
- SMHI $6.88
- NKTX $2.35
- Average True Range (ATR)
- SMHI 0.22
- NKTX 0.15
- MACD
- SMHI -0.03
- NKTX -0.00
- Stochastic Oscillator
- SMHI 1.49
- NKTX 19.15
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides world-wide marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations including wind farms; handle anchors and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico); Africa and Europe; Middle East and Asia and Latin America.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.